Tags

Type your tag names separated by a space and hit enter

Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).
Infect Dis Clin North Am. 2014 Dec; 28(4):601-13.ID

Abstract

Postexposure prophylaxis (PEP), which is designed to prevent human immunodeficiency virus (HIV) infection after an exposure, is one of several strategies for HIV prevention. PEP was first used after occupational HIV exposures in the late 1980s, with the Centers for Disease Control and Prevention issuing the first set of guidelines that included considerations regarding the use of antiretroviral agents for PEP after occupational HIV exposures in 1990. Use of PEP has been extended to nonoccupational exposures, including after sexual contact or injection-drug use. This article provides a rationale for PEP, assessment of the need for PEP, and details of its implementation.

Authors+Show Affiliations

Department of Internal Medicine, The University of Iowa College of Medicine, Infectious Diseases SW34-J GH, Iowa City, IA 52242, USA.Clinical Center, National Institutes of Health, Bethesda, Building 10-CRC, Rm 6-2551, MD 20892, USA. Electronic address: DHenderson@cc.nih.gov.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

25287589

Citation

Beekmann, Susan E., and David K. Henderson. "Prevention of Human Immunodeficiency Virus and AIDS: Postexposure Prophylaxis (including Health Care Workers)." Infectious Disease Clinics of North America, vol. 28, no. 4, 2014, pp. 601-13.
Beekmann SE, Henderson DK. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers). Infect Dis Clin North Am. 2014;28(4):601-13.
Beekmann, S. E., & Henderson, D. K. (2014). Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers). Infectious Disease Clinics of North America, 28(4), 601-13. https://doi.org/10.1016/j.idc.2014.08.005
Beekmann SE, Henderson DK. Prevention of Human Immunodeficiency Virus and AIDS: Postexposure Prophylaxis (including Health Care Workers). Infect Dis Clin North Am. 2014;28(4):601-13. PubMed PMID: 25287589.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers). AU - Beekmann,Susan E, AU - Henderson,David K, Y1 - 2014/10/05/ PY - 2014/10/8/entrez PY - 2014/10/8/pubmed PY - 2015/6/4/medline KW - HIV KW - HIV PEP KW - Nonoccupational exposure KW - Occupational exposure KW - Postexposure prophylaxis SP - 601 EP - 13 JF - Infectious disease clinics of North America JO - Infect Dis Clin North Am VL - 28 IS - 4 N2 - Postexposure prophylaxis (PEP), which is designed to prevent human immunodeficiency virus (HIV) infection after an exposure, is one of several strategies for HIV prevention. PEP was first used after occupational HIV exposures in the late 1980s, with the Centers for Disease Control and Prevention issuing the first set of guidelines that included considerations regarding the use of antiretroviral agents for PEP after occupational HIV exposures in 1990. Use of PEP has been extended to nonoccupational exposures, including after sexual contact or injection-drug use. This article provides a rationale for PEP, assessment of the need for PEP, and details of its implementation. SN - 1557-9824 UR - https://www.unboundmedicine.com/medline/citation/25287589/Prevention_of_human_immunodeficiency_virus_and_AIDS:_postexposure_prophylaxis__including_health_care_workers__ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0891-5520(14)00058-0 DB - PRIME DP - Unbound Medicine ER -